Wave Life Sciences Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 13:26:32 ET
More on Wave Life Sciences
- Wave Life Sciences: WVE-006 Now In Focus, Navigating Opportunity And Risk
- Wave Life Sciences Ltd. (WVE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Wave Life Sciences Ltd. (WVE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Wave Life Sciences receives back rights to AATD therapy from GSK
- Wave Life Sciences prices upsized $350M stock offering
Read the full article on Seeking Alpha
For further details see:
Wave Life Sciences Q4 2025 Earnings Preview
Wave Life Sciences Ltd.
NASDAQ: WVE
WVE Trading
-1.7% G/L:
$13.90 Last:
656,232 Volume:
$13.79 Open:
WVE Latest News
March 05, 2026 08:30:00 am
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
February 26, 2026 07:30:00 am
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
WVE Stock Data
$2,455,817,603
74,781,401
10.3%
63
N/A
Biotechnology & Life Sciences
Healthcare
SG
